Join us and your peers for the Emerging Biotech Upstream Forum to discuss latest trends, innovations, and technologies to help you speed up your molecule to clinic: from cell line development to bioreactor scale-up.
|10:30 - 11:00||Registration|
|11:00 - 11:50||The CHOZN® GS cell line: Optimized reagents and processes for biopharmaceutical cell line development|
|Kate Achtien, Senior R&D Scientist, MilliporeSigma|
|11:50 - 12:40||MilliporeSigma’s advanced capabilities in media development|
|Avril A. Lawshé, Senior R&D Scientist, MilliporeSigma|
|12:40 - 1:00||Break|
|1:00 - 1:30||BioReliance® services: From clone selection to cell bank release|
|Jennifer Hayne, Sales Director for BioReliance® Biologics Testing, MilliporeSigma|
|1:30 - 2:00||From concept to market: Development of biologics from start to finish|
|Dana Crouse, Associate Director Business Development BioReliance® End-to-End Solutions, MilliporeSigma|
|2 :00 - 2 :15||Wrap Up|
The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the US and Canada.
*Agenda subject to change. Attendance to the “Upstream Forum” is limited and available to pharma/biopharma manufacturers and academics only. The offer does not extend to any company that provides products or services to the pharma/biopharma industry. MilliporeSigma reserves the right to revoke or refuse participation at any times.
Lunch and coffee breaks are provided courtesy of MilliporeSigma. Travel costs, hotel accommodations and any other costs incurred are at the expense of the attendees.
EMD Millipore + Sigma-Aldrich =
The life science business of
Merck KGaA, Darmstadt, Germany
Hilton Garden Inn San Francisco Airport North
670 Gateway Blvd, South San Francisco, CA 940801
DoubleTree by Hilton San Diego - Del Mar
11915 El Camino Real, San Diego, CA 92130